BNP Paribas Financial Markets
DSGN icon

BNP Paribas Financial Markets’s Design Therapeutics DSGN Stock Holding History

BNP Paribas Financial Markets’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$535K Sell
50,272
-44,556
-47% -$451K ﹤0.01% 3547
2025
Q4 		$889K Buy
94,828
+89,695
+1,747% +$702K ﹤0.01% 3196
2025
Q3 		$38.7K Buy
5,133
+1,310
+34% +$6.56K ﹤0.01% 4701
2025
Q2 		$12.9K Sell
3,823
-49,049
-93% -$184K ﹤0.01% 4777
2025
Q1 		$204K Buy
52,872
+12,583
+31% +$60K ﹤0.01% 3680
2024
Q4 		$249K Buy
+40,289
New +$233K ﹤0.01% 3739

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BNP Paribas Financial Markets's DSGN Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Design Therapeutics (DSGN) stake by 47% in Q1 2026, selling an estimated $451K and leaving 50,272 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #3547.

BNP Paribas Financial Markets first reported a position in DSGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $889K in Q4 2025. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • BNP Paribas Financial Markets held 50,272 shares of Design Therapeutics worth $535K as of Q1 2026.
  • BNP Paribas Financial Markets sold 44,556 Design Therapeutics shares in Q1 2026, an estimated $451K.
  • Design Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3547 holding.
  • BNP Paribas Financial Markets first reported a position in Design Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Design Therapeutics position peaked at $889K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.